Cyclopropanecarboxylic Acid Amide

Cyclopropanecarboxylic Acid Amide

SCHEMBL2857322

NC(=O)C1CC1.O=C(O)c1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.48
SIRT1 Q96EB6 1/20 0.48
MAPK10 P53779 1/20 0.45
MAPKAPK2 P49137 1/20 0.39
IKBKB O14920 1/20 0.38
PIP5K1C O60331 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA5A P35218 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
PLAU P00749 2/20 0.36
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
NTRK1 P04629 1/20 0.34
FLT3 P36888 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859049 0.90 MAPK10 (0.43) SIRT2SIRT1MAPK10MAPKAPK2IKBKB
Cyclopropanecarboxylic Acid Amide SCHEMBL2861585 0.82 NPC1 (0.40) MAPKAPK2CA12BTK
SCHEMBL2857326 0.81 PIP5K1C (0.48) SIRT2SIRT1MAPK10MAPKAPK2PIP5K1C
Cyclopropanecarboxylic Acid Amide SCHEMBL2864932 0.80 SIRT2 (0.48) SIRT2SIRT1IKBKBPIP5K1CCA12
SCHEMBL4343158 0.79 MAPK10 (0.54) SIRT2SIRT1MAPK10MAPKAPK2PIP5K1C
SCHEMBL2863679 0.79 JAK2 (0.44) SIRT2SIRT1MAPK10MAPKAPK2IKBKB
SCHEMBL13198255 0.77 SIRT2 (0.40) SIRT2SIRT1MAPK10MAPKAPK2IKBKB
SCHEMBL2857820 0.75 ACLY (0.42) SIRT2SIRT1MAPK10MAPKAPK2IKBKB
SCHEMBL2864567 0.75 MAPKAPK2 (0.48) SIRT2SIRT1MAPK10MAPKAPK2IKBKB
SCHEMBL13198221 0.75 SIRT2 (0.41) SIRT2SIRT1MAPK10MAPKAPK2IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 SIRT2 1519/4885SIRT1 793/4885MAPK10 29/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 SIRT2 2133/4885SIRT1 1299/4885MAPK10 27/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 SIRT2 1519/4885SIRT1 793/4885MAPK10 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.